about
Role of RANKL inhibition in osteoporosisCausal assessment of dietary acid load and bone disease: a systematic review & meta-analysis applying Hill's epidemiologic criteria for causalityVitamin D supplementation in infancy for improving bone densityBisphosphonates for osteoporosis in primary biliary cirrhosisBisphosphonates for osteoporosis in primary biliary cirrhosisVitamin K for the prevention and treatment of osteoporosis in post-menopausal womenAlendronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenEtidronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenRisedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal womenCalcium supplementation for improving bone mineral density in childrenOne world, one womanHigh-density association study of 383 candidate genes for volumetric BMD at the femoral neck and lumbar spine among older menAssociation between alcohol consumption and both osteoporotic fracture and bone densitySelective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifenePhosphate decreases urine calcium and increases calcium balance: a meta-analysis of the osteoporosis acid-ash diet hypothesisNational athletic trainers' association position statement: preventing, detecting, and managing disordered eating in athletesAn Increased Risk of Osteoporosis during Acquired Immunodeficiency SyndromeComprehensive Geriatric Assessment (CGA) in general practice: results from a pilot study in Vorarlberg, AustriaAssessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directionsCOPD and osteoporosis: links, risks, and treatment challengesDual-Energy X-Ray Absorptiometry: Beyond Bone Mineral Density DeterminationThe obesity of boneEfficacy and Safety of Denosumab in Postmenopausal Women With Osteoporosis: A Meta-AnalysisDenosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patientsThe Chinese skeleton: insights into microstructure that help to explain the epidemiology of fractureConsequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursorsManaging osteoporosis in ulcerative colitis: something new?Treatment of primary osteoporosis in menOsteoporosis in paediatric patients with spina bifidaManagement of endocrine disease: Secondary osteoporosis: pathophysiology and managementEpidemiology and management of osteoporosis in the People's Republic of China: current perspectivesClinical imaging of bone microarchitecture with HR-pQCTParathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosisComprehensive analyses of how tubule occlusion and advanced glycation end-products diminish strength of aged dentinProlonged bioluminescence monitoring in mouse ex vivo bone culture revealed persistent circadian rhythms in articular cartilages and growth platesInfluence of exercise on bone remodeling-related hormones and cytokines in ovariectomized rats: a model of postmenopausal osteoporosisBone anabolics in osteoporosis: Actuality and perspectivesMechanisms involved in altered bone metabolism in diabetes: a narrative reviewOsteoporosis Associated with Chronic Obstructive Pulmonary DiseaseAbaloparatide
P2860
Q21195417-66CC70C3-4A40-43B4-801A-4AE3148FDB73Q21245925-E374323C-0AE3-411E-9B4E-D53CF2473220Q24201552-9E157796-CA89-4246-8AB5-0FA99167D221Q24234283-52F3B880-A9B2-477C-BD6F-8B2A84509771Q24234967-B67C98BA-400B-492E-A8AD-69711E651604Q24239937-AC8EA22B-FA33-4F2E-806E-E86F4C03C92CQ24242258-F486D4D6-5145-4FB5-A14A-7D015156EF25Q24242665-EB0720B6-A38D-4CC6-84E8-8ACBC5E60E0BQ24242674-0DFD95BE-055B-451D-B311-5EF01DF84D79Q24246305-E474BAC7-138A-47EA-962F-6E97B42BBD5FQ24612879-6365105A-F4D0-436A-96A6-9190236F4501Q24643761-BC0C98E0-21CE-41EE-A604-1059741C876BQ24649823-31146BD1-DF76-4975-9D9E-839A0B9BD9E3Q24652524-BF1851B4-395A-4C47-9B3F-54F19D041889Q24653355-78B3703F-B501-4316-8CC8-A1E77350D7C0Q24653721-8B378E2B-E728-4D64-AF98-E96E466848F4Q24791238-854ADD71-FB54-4345-AF90-2791A13AE0AAQ24795813-2F0026F1-B5D7-4697-ABF9-AF07563CC774Q26750574-28ED9468-97CA-4D64-898D-D0ADF8F3720CQ26751371-A7459F23-8BE7-4C82-8695-D79D78D5B215Q26753188-C3C6EED3-316F-49C8-8123-D51C1E1F2381Q26775713-E70DC83C-DD86-4263-9620-964C8B8BCB02Q26778216-E4B54A4C-C051-4EBC-87DD-BD99905F76E7Q26824762-C71B205E-8111-4AD8-BB84-AEE37B0CB0A1Q26863740-D1EA8B6F-DAD3-46AA-842D-8BBBA5AAF8C2Q26864483-63FF6C83-E89A-49A7-888A-A7BA4488154AQ26864691-24033D84-32BC-4883-8083-27D3E23776E1Q26991748-9C05A8BE-458A-46B0-A2B7-860E826E35FFQ26996355-95ABB5C4-EDA2-4052-A01D-F4CB5B874DBDQ26998249-E0A7484F-F375-4121-89E2-E8CB52D0EF96Q27005978-2F1EB998-7397-41AF-B5FE-21F60EE23A6CQ27010454-9028BEEA-5621-41CA-BD91-2E2A2FA0E330Q27024513-8F9A579A-DEED-4789-A60D-D9B2F15F41F6Q27300823-E8635167-DDF7-490D-AC15-CC98F385C895Q27303477-ACFCEB24-292C-4906-BB57-E10E7E5209C2Q27325588-67561E0A-138F-49F8-8365-99D946175E87Q27691122-2C759B59-CE60-4C35-868D-5947ECD1B578Q28068109-AD96F2BA-4DE3-451A-B9D1-6E3CFD20FBC9Q28070018-E26D2F40-7940-4CB2-933A-9905C3325CB1Q28073605-F0CFF28B-B726-425B-A32B-19CEE8AF9BCE
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Osteoporosis prevention, diagnosis, and therapy.
@ast
Osteoporosis prevention, diagnosis, and therapy.
@en
Osteoporosis prevention, diagnosis, and therapy.
@nl
type
label
Osteoporosis prevention, diagnosis, and therapy.
@ast
Osteoporosis prevention, diagnosis, and therapy.
@en
Osteoporosis prevention, diagnosis, and therapy.
@nl
prefLabel
Osteoporosis prevention, diagnosis, and therapy.
@ast
Osteoporosis prevention, diagnosis, and therapy.
@en
Osteoporosis prevention, diagnosis, and therapy.
@nl
P356
P1476
Osteoporosis prevention, diagnosis, and therapy.
@en
P2093
NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy
P304
P356
10.1001/JAMA.285.6.785
P407
P577
2001-02-01T00:00:00Z